Foundation for Enabling Biotechnology Innovation Act
S 2696 establishes a nonprofit "Foundation for Enabling Biotechnology Innovation" under the National Science Foundation to accelerate the commercialization of biotechnology products in the U.S. The Foundation will foster public-private partnerships, convene stakeholders to develop recommendations on emerging biotech products, and support international market access for U.S. biotech companies. It will operate through a diverse Board of Directors (excluding federal employees) and receive $4 million annually from the NSF, with no regulatory authority. The Foundation aims to complement existing federal efforts without duplicating them, focusing on collaboration, education, and market development for biotechnology products.
Bill status
in committee
1 of 4 stages cleared
Introduction
Sep 2025
Committee Review
Floor Vote
President
Introduced Sep 3, 2025
Last action Sep 3, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Sep 3, 2025
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Sep 3, 2025
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2696
Scope: US
Hi! I can help you understand S 2696. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline